同源结构域相互作用蛋白激酶2在瘢痕疙瘩角质形成细胞组织纤维化发病机制中的作用
该研究探讨同源结构域相互作用蛋白激酶2(HIPK2)在瘢痕疙瘩纤维化发病中的作用,培养原代正常皮肤和瘢痕疙瘩角质形成细胞,经转化生长因子β1预处理后转染HIPK2小干扰RNA,采用实时定量聚合酶链反应和蛋白质印迹分析。结果显示瘢痕疙瘩角质形成细胞中HIPK2较正常皮肤角质形成细胞明显升高,HIPK2通过TGF-β1-SMAD3诱导正常皮肤角质形成细胞上皮-间质转化标志物表达,转染HIPK2小干扰RNA后该效应被显著削弱,作者认为HIPK2是瘢痕疙瘩发病的关键因子,可能成为抗瘢痕疙瘩治疗的新药物靶点。
要点
- 瘢痕疙瘩角质形成细胞中HIPK2较正常皮肤角质形成细胞明显升高
- HIPK2通过TGF-β1-SMAD3诱导正常皮肤角质形成细胞上皮-间质转化标志物表达
- 转染HIPK2小干扰RNA后TGF-β1相关上皮-间质转化标志物和SMAD3磷酸化效应被显著削弱
核心结论
- 作者认为HIPK2是瘢痕疙瘩发病的关键因子,提示HIPK2可能成为抗瘢痕疙瘩治疗的新潜在药物靶点。
研究设计与样本
- 体外细胞研究:培养原代正常皮肤和瘢痕疙瘩角质形成细胞,经TGF-β1预处理后分别转染乱序小干扰RNA和抗HIPK2小干扰RNA,采用实时定量聚合酶链反应和蛋白质印迹分析。
主要发现
- 瘢痕疙瘩来源角质形成细胞中HIPK2较正常皮肤角质形成细胞明显升高。
- HIPK2通过TGF-β1-SMAD3诱导正常皮肤角质形成细胞上皮-间质转化标志物表达。
- 细胞转染HIPK2小干扰RNA后,外源TGF-β1所致上皮-间质转化标志物和SMAD3磷酸化效应被显著削弱。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epithelial-mesenchymal transition (EMT) plays a critical role in fibrotic keloid formation, which is characterized by excessive collagen and extracellular matrix synthesis and deposition. Growing evidence suggests that the serine/threonine kinase homeodomain-interacting protein kinase 2 (HIPK2) acts upstream of several major fibrosis signaling pathways; however, the role of HIPK2 in the keloid fibrogenesis remains unknown. In the current study, we investigated the roles of HIPK2 in the pathogenesis of keloids. Primary normal skin and keloid keratinocytes were cultured and pretreated with transforming growth factor (TGF)-β1. Next, keratinocytes were transfected with scrambled small interfering RNA (siRNA) and anti-HIPK2 siRNA. The TGF-β1-associated HIPK2 alterations were investigated by quantitative real-time polymerase chain reaction. Protein levels were analyzed by western blotting. The HIPK2 was markedly increased in the keloid-derived keratinocytes compared with normal skin keratinocytes. In addition, HIPK2 induced the expression of EMT markers in normal skin keratinocytes by TGF-β1-SMAD family member 3 (SMAD3). The effect of TGF-β1-related EMT markers and SMAD3 phosphorylation in response to added TGF-β1 was significantly abrogated when the cells were transfected with HIPK2 siRNA. We conclude that HIPK2 is a crucial factor in the pathogenesis of keloids, suggesting that HIPK2 might be a novel potential drug target for antikeloid therapy.
引用
- Zhao YX, Zhang GY, Wang AY, et al. Role of Homeodomain-Interacting Protein Kinase 2 in the Pathogenesis of Tissue Fibrosis in Keloid-Derived Keratinocytes. Ann Plast Surg. 2017. PMID: 29053518. doi:10.1097/SAP.0000000000001243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。